Richard Sullivan

2 ta ish

School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; Institute of Cancer Policy, King's College London, London, UK; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK

1. International Cancer Control Partnership

   Richard Sullivan

   MaqolaGlobal Public Health Policies and EpidemiologyThe Lancet Oncology20141 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000003

2. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

   Camille Maringe, James Spicer, Melanie Morris +5

   MaqolaCOVID-19 and healthcare impactsThe Lancet Oncology20201 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.000034